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Subtotal esophagectomy with extended lymph node dissection is a standard procedure for thoracic esophageal squamous cell
carcinoma. Three-ﬁeld lymphadenectomy, including neck dissection, is a standard type of lymph node dissection for complete
clearance of tumor cells. Based on various series of analyses for lymph node metastases, the appropriate indication for neck dissec-
tion has been clariﬁed. Herein, we describe the established techniques of neck dissection and review recent topics of three-ﬁeld
lymph node dissection for thoracic esophageal squamous cell carcinoma.
1.Introduction
Neck dissection was introduced in the early 1980s based on
analyses of the spreading pattern of lymph node metastases
fromthoracicesophagealsquamouscellcarcinoma(SCC)[1,
2]. Extended lymph node dissection including neck, medi-
astinal, and abdominal lymph nodes has been called three-
ﬁeld lymph node dissection (3FLD) [3]. The neck dissection
includes cervical paraesophageal nodes, deep cervical nodes,
and supraclavicular nodes, and it was subsequently adopted
as the standard surgical procedure for thoracic esophageal
SCC at high-volume centers in Japan in the late 1980s [4, 5].
A similar surgical procedure was also introduced in Western
nations in the late 1990s [6, 7].
2. Indicationsfor Neck Dissection
Despite recent advances in preoperative staging, including
computed tomography, positron emission tomography, and
ultrasonography, the pathological ﬁndings after 3FLD indi-
cate that the overall accuracy, sensitivity, and speciﬁcity of
clinical staging remain too low. More than 75% of cervical
metastases are not detected before surgery. Therefore, the in-
dication for neck dissection should be determined by tumor
location, tumor depth, and/or intraoperative nodal assess-
ment of recurrent nerve nodes. A summary of the prevalence
of positive cases of cervical lymph node metastases and over-
all 5-year survival after 3FLD is shown in Table 1.
The prevalence of positive cervical lymph nodes associ-
ated with tumors in the upper part of the thoracic esophagus
was signiﬁcantly higher than that derived from tumors in
the lower part of the esophagus (upper, 48%; middle, 28%;
lower, 13%) [4]. Among the patients with lower third eso-
phageal tumors, none of those with T1b tumors had cervical
metastasis, whereas 16% of those with T2-T4 tumors did.
Moreover, 29% of patients with tumors in the upper third
of the esophagus had initial lymph node metastases into the
cervical ﬁeld according to the data of patients with solitary
lymph node metastases. This prevalence was signiﬁcantly
higher than that of patients with tumors in the middle or
lower third section of the esophagus (13% and 0%, resp.).
Recurrent nerve nodes may be sentinel nodes that predict
cervical lymph node metastases in patients with tumors in
the middle or lower third of the esophagus [8]. Although
neck dissection became a standard procedure for upper third
tumors, this procedure is not essential for lower third tu-
mors. Application for middle third tumors is still contro-
versial. Overall survival was signiﬁcantly better in the 3FLD
group than in the two-ﬁeld lymph node dissection (2FLD)
group (without neck dissection) if the patients had recurrent
nerve lymph node metastases, but there was no signiﬁcant
diﬀerencebetweenthetwogroupsifthepatientsdidnothave2 International Journal of Surgical Oncology
Table 1: Positive rates of cervical lymph node metastases and overall ﬁve-year survival rates after three-ﬁeld lymph node dissection.
Positive rates of cervical lymph node metastases according to
tumor location Overall 5-year survival rates according to pN status
Authors Upper (%) Middle (%) Lower (%) Total (%) pN0 (%) pN1 (%) pN1 in cervical
ﬁeld (%) Total (%)
Isono et al. [3] 4 23 81 93 3 N A N A N A 3 4
Altorki et al. [6] 1 35 93 33 6 8 8 3 3 2 5 5 1
L e r u te ta l .[ 7] 44.4 26.2 23 23.6 80.2 24.5 12.8 41.9
Shiozaki et al. [8] 23.5 34.5 10.5 27.5 NA NA NA 48.5
Shimada et al. [4] 4 83 01 82 6 6 8 3 7 3 2 5 2
Tachimori et al. [9] 21.2 25.5 5.6 17 85 30∼50 30 NA
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Figure 1: Lone Star Retractor System to make operative ﬁeld.
recurrent nerve lymph node metastases [8]. Neck dissection,
therefore, may improve survival only for patients with re-
current nerve node metastases.
3.SurgicalProcedureof NeckDissection
A summary of neck dissection for thoracic esophageal squa-
mous cell carcinoma has been described [4, 5]. Patients were
placed in the supine position so that a U-shaped neck inci-
sion could be made. Through the cervical incision, the Lone
Star Retractor System (Cooper Surgical, Inc.) was used to
make the operative ﬁeld (Figure 1). We performed medi-
astinal lymph node dissection through a right transthoracic
approach before neck dissection, so the remainder of the
recurrent nerve nodes was located posterior and lateral to
the carotid sheath. Thus, the cervical lymph nodes included
a continuous, anatomically inseparable chain of nodes that
extended from the superior mediastinum to the lower neck
(Figure 2). The sternomastoid and strap muscles were pre-
served, and the cervical nodes (internal jugular nodes below
the level of the cricoid cartilage, supraclavicular nodes, and
cervical paraesophageal nodes) were removed bilaterally
(Figure 3). The paraesophageal nodes (including the recur-
rent nerve nodes in the cervicothoracic junction) were classi-
ﬁed as cervical or upper mediastinal nodes according to their
position relative to the bifurcation between the right com-
mon carotid and right subclavian artery.
4.Survivalafter3FLD
The 5-year survival in consecutive studies after the introduc-
tion of neck dissection was 34–52%, with surgical mortality
valuesof1.2–5%.Theoverall5-yearsurvivalwas57–88%for
node-negative patients and 25–37% for patients with nodal
metastases [3–5]. Although lymph node metastases into the
cervical ﬁeld are classiﬁed as distant metastases, 13–32% of
patients survived >5 years after clearance of positive cervical
nodes [3–5]. Similar survival values were obtained in recent
Western studies reported by Altorki et al. [6]a n dL e r u te ta l .
[7]. More recent series also showed good survival curves in
patients with positive neck lymph nodes, which were equiv-
alent to those of patients with positive mediastinal nodes
[9].
5. Survivalof Patients with
Positive Neck Lymph Nodes
Among cervical node-positive patients, those with tumors
in the upper esophagus showed signiﬁcantly better survival
than those with tumors in the lower esophagus [4]. Hence,International Journal of Surgical Oncology 3
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Figure 2: Dissection of left cervical paraesophageal lymph nodes. Left laryngeal recurrent nerve was taped.
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Figure 3: Dissection of the right side supraclavicular lymph nodes.
cervical nodes may be regional nodes that should be rou-
tinely dissected (at least in patients with tumors in the upper
part of the esophagus). The number of patients with abdom-
inal node metastases from upper esophageal tumors was
small, so a signiﬁcant association between abdominal node-
positive patients and tumor location was not observed. The
real impact of neck dissection on overall survival should be
evaluated by randomized controlled clinical trials. Two ran-
domized trials were performed in Japan by Kato et al. [10]
and Nishihira et al. [11], who compared 2FLD and 3FLD
from the late 1980s to early 1990s. Both studies showed that
extended lymphadenectomy can prevent recurrence and
prolong survival after resection of thoracic esophageal car-
cinoma, with an advantage of 3FLD over 2FLD. The overall
5-year survival for 3FLD and 2FLD patients was 49% and
33% (P<0.01) [10] and 66% and 48% (P = 0.19) [11]. Ex-
tended lymphadenectomy increased the R0 resection rate at
lymph node levels, which seemed to reduce the incidence of
locoregional recurrence, and the available data suggested a
potential survival beneﬁt for 3FLD patients. It appears that
positive cervical lymph nodes in patients with tumors in
the upper third part of the esophagus should no longer be
considered as distant metastases but rather as regional meta-
stases.
6. Difﬁculties in PerformingRandomized Trials
Upper mediastinal lymph node dissection and recurrent
nerve node dissection are essential. However, the optimal
indication for neck dissection for middle or lower third tho-
racic esophageal carcinoma remains controversial. There re-
mains a need for randomized studies to compare 3FLD with
2FLD for middle or lower third esophageal carcinoma with-
out clinically detectable cervical node metastases. Because of
the diﬃculties involved in recruiting a suﬃcient number of
patients and the technical diﬃculties associated with neck
dissection, such randomized trials have not been performed
in Western countries. Conducting prospective randomized
trials to compare the survival curves for 2FLD and 3FLD
groups will be diﬃcult because most surgeons in high-vol-
ume centers in Japan prefer neck dissection for thoracic eso-
phageal SCC.
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